S 2520
106th Congress
Senate
Health
Administrative procedure
Commerce
Congress
Congressional reporting requirements
Customs administration
Department of Health and Human Services
Drug adulteration
Drug industry
Drugs
Foreign Trade and International Finance
Government Operations and Politics
Government paperwork
Governmental investigations
Imports
Intellectual property
Law
Patents
Pharmacists
Prescription pricing
Medicine Equity and Drug Safety Act of 2000
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 9, 2000
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 9, 2000
Sponsor introductory remarks on measure. (CR S3693-3694)
May 9, 2000
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Medicine Equity and Drug Safety Act of 2000 - Amends the Federal Food, Drug, and Cosmetic Act to require regulations permitting the importation into the United States of covered products (prescription drugs).
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill text
1 version
- Introduced in Senate Formatted Text PDF
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 2520: Medicine Equity and Drug Safety Act of 2000. 106th Congress. Open America. https://openamerica.io/bill/106-S-2520/
"S. 2520: Medicine Equity and Drug Safety Act of 2000." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-S-2520/.
S. 2520, 106th Cong. (2026), https://openamerica.io/bill/106-S-2520/.
[S. 2520: Medicine Equity and Drug Safety Act of 2000](https://openamerica.io/bill/106-S-2520/)